NCT04166825Recruiting
Ovarian Hyperstimulation and Fibrin Clot Properties.
The Impact of Different Ovarian Hyperstimulation Protocols on Coagulation and Fibrinolysis.
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
The impact evaluation of ovarian hyperstimulation on coagulation and fibrinolysis in infertile women. Comparative analysis between different ovarian stimulation protocols on thrombin formation and efficiency of fibrinolysis in women diagnosed with infertility.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 13 Nov 2019
- Start date
- 18 Nov 2019
- Primary completion date
- Jan 2026
- Lead sponsor
- Jagiellonian University
- Diseases
- Endometriosis
- NCT number
- NCT04166825
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 18 Nov 2019 to the primary completion date, Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- oral contraceptives use within previous 3 months
- dienogest therapy within 3 months until ART
- the presence of known VTE risk factors, including obesity, recent major surgery with prolonged immobilization or trauma,
Other illness
- severe hypertension
- diabetes mellitus
- antiphospholipid syndrome,
- known malignancy,
- any chronic inflammatory diseases (e.g. rheumatoid arthritis)
Lab values
- advanced chronic renal disease (estimated glomerular filtration rate \[eGFR\] \<30 ml/min),
- international normalized ratio (INR) more than 1.2 at the day of blood draw
Other
- ovarian involvement
- thrombotic events in the medical history
- deficiency of antithrombin, protein C or protein S,
- pregnancy.
Who the study is looking for
- infertility defined based on the WHO 2010 criteria
Age in the registry: 18 years to 40 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Gynecological Endocrinology Jagiellonian University Medical College Coordinator of this site? Confirm its status | Krakow | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.